"Jerusalem-based Brainsway has been granted investigational device exemptions from the FDA to test the company's Deep TMS (Transcranial Magnetic Stimluation) device for the treatment of cocaine addiction.
Brainsway will conduct a clinical trial in the US, which will include 30 patients and be financed by the National Institute on Drug Abuse (NIDA), a unit of the National Institutes of Health.
If and when the Deep TMS is commercialized for the treatment of cocaine addiction, Brainsway will pay royalties to NIDA.
The Deep TMS is a non-invasive treatment of brain disorders that activates or suppresses neuron activity in the brain to treat psychiatric or neurological disorders.
Brainsway, run by CEO Uzi Sofer, is dedicated to the development and marketing of Deep TMS, that the company describes as 'a novel, noninvasive medical device for treatment of a wide range of neurological and psychopathological disorders.'
Israel's financial daily Globes reports that Brainsway has initiated procedures to list on Nasdaq in the fourth quarter of 2010." (source)
Popular Posts
-
On the 1st April 2015, Iraqi born British Pro-Israel activist Orim Shimshon came to visit Israel and we invited him to give a talk to a roo... -
NOTICE: This article I submitted won in the quarter-finals of the Pro-Israel blog-off competition . When we seek information on new techn... -
"Between 1920 and 1970, 900,000 Jews were expelled from Arab and other Muslim countries. The 1940s were a turning point in this tragedy...